查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829888

2025年全球腫瘤栓塞裝置市場報告

Tumor Embolization Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腫瘤栓塞器械市場規模強勁成長，從2024年的14,936億美元成長到2025年的15,874.8億美元，複合年成長率為6.3%。這段時期的成長可歸因於微創手術、技術進步、癌症發生率上升以及人口老化。

預計未來幾年腫瘤栓塞器械市場規模將強勁成長，到2029年將達到22,546.7億美元，複合年成長率為9.2%。預測期內的成長歸因於個人化醫療、聯合治療、影像導引栓塞、遠端醫療和遠距會診。預測期內的主要趨勢包括栓塞劑、經動脈化療栓塞術 (TACE)、安寧療護栓塞以及影像導引手術的創新。

腫瘤栓塞裝置是用於腫瘤治療的微創裝置。這些裝置用於切斷腫瘤的血液供應或將治療藥物直接輸送到腫瘤部位。

腫瘤栓塞器械主要分為放射性和非放射性兩類。非放射性栓塞器械包括用於腫瘤治療的材料，例如發泡明膠、三丙烯酸明膠微球和聚乙烯醇 (PVA)。這些應用與癌性和非癌性腫瘤均相關，其終端用戶包括醫院、癌症治療中心、加護病房和外科中心等。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供腫瘤栓塞設備的市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的腫瘤栓塞設備細分市場、市場趨勢和機遇，以及您在腫瘤栓塞設備行業取得成功所需的數據。本腫瘤栓塞設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年預測成長率為9.2%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這一影響，因為校準微球和可分離栓塞線圈的供應鏈中斷，這些產品主要來自愛爾蘭和西班牙等主要地區，這可能導致介入性腫瘤手術的成本上升。此外，由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這一影響也可能波及更廣泛的領域。

預計全球癌症發生率的上升將在預測期內推動腫瘤栓塞設備市場的成長。例如，英國最大的醫療保健慈善機構麥克米倫癌症援助組織在2022年10月預測，癌症患者數量將在2025年達到350萬，2030年達到400萬，2040年達到530萬。因此，全球癌症發生率的上升可能會在未來幾年刺激對腫瘤栓塞設備的需求。

不斷成長的醫療支出推動了腫瘤栓塞器材市場的發展。醫療支出包括與提供醫療服務相關的所有費用，例如計劃生育、營養計劃和緊急醫療支援。醫療支出的成長推動了各種健康相關產品的發展，包括腫瘤栓塞器材。例如，根據英國預算責任辦公室 (OBR) 和財政部（英國非政府公共機構）的經濟預測，英國的醫療支出預計將從 2022/23 年的 1,820 億英鎊（2,317 億美元）增加到 2024/25 年的 1,920 億英鎊（2,444.3 億美元）。因此，醫療支出的上漲是推動腫瘤栓塞器材市場成長的關鍵因素。

腫瘤栓塞設備市場的主要參與者正在開發血管造影術系統等創新產品，以提高腫瘤標靶治療的準確性和有效性。血管造影術系統是用於可視化血管和評估體內血流的專用影像工具。例如，2022 年 6 月，德國醫療保健公司西門子 (Siemens Hertiniers) 推出了 Artis Icono Ceiling。這款天花板血管造影術系統旨在提高腫瘤栓塞和其他介入手術的準確性。 Artis Icono Ceiling 具有快速獲取3D(3D) 資料的功能，僅需 2.5 秒即可從患者頭部獲取影像，4 秒即可從側面獲取影像。這最大限度地減少了運動偽影並減少了對造影劑的需求。該系統的多功能性使其適用於各種專業，包括介入性放射學和心臟病學。

腫瘤栓塞設備市場的主要企業正致力於推出 Eye90 等創新療法，以最大化市場收益。 Eye90 微球是一種 Y90 放射栓塞設備，專門用於治療肝臟腫瘤，特別是肝細胞癌。 2023 年 5 月，加拿大醫療設備公司 ABK Biomedical 獲得美國食品藥物管理局(FDA) 的臨床實驗試驗豁免 (IDE)核准，啟動 Eye90 微球治療肝細胞癌的多中心關鍵試驗。微球採用專有製造製程生產，尺寸分佈均勻，放射性濃度高。它們旨在向腫瘤發射高劑量的輻射，同時最大限度地減少對健康組織的照射。

2022 年 8 月，美國醫療設備製造商波士頓科學公司收購了美國栓塞凝膠開發商 Obsidio，以加強其介入性腫瘤學和栓塞產品組合。

腫瘤栓塞設備市場的主要企業包括波士頓科學公司、美敦力公司、泰爾茂公司、Sirtex Medical Limited、Merit Medical Systems Inc.、Cook Medical LLC、AngioDynamics Inc.、西門子醫療股份公司、強生公司、Penumbra Inc.、Teleflex Incorporated、Meril Life Sciences Pvt、強生公司、Penumbra Inc.、Teleflex Incorporated、Meril Life Sciences Pvt、Guer betvt、Stechnology. Inc.、Delcath Systems Inc.、Endoshape Inc.、InSitu Technologies Inc.、Monteris Medical Corporation、NeuWave Medical Inc.、Neoprobe Corporation、OncoSec Medical Incorporated、Helomics Corporation、Hologic、Surefire Medical Inc.、Varian Medical Systems Inc.

2024年，北美是腫瘤栓塞設備市場最大的地區。亞太地區是腫瘤栓塞設備市場的第二大地區。腫瘤栓塞設備市場報告涵蓋以下地區：亞太地區、西歐、東歐、北美、南美、中東和非洲。

腫瘤栓塞設備市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。

腫瘤栓塞器械市場涵蓋放射性和非放射性栓塞器械的銷售。此市場的價值為出廠價，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤栓塞設備：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球腫瘤栓塞裝置市場：成長率分析
  • 全球腫瘤栓塞設備市場表現：規模與成長，2019-2024
  • 全球腫瘤栓塞設備市場預測：規模與成長，2024-2029，2034
  • 全球腫瘤栓塞設備：總目標市場（TAM）

第6章 市場細分

  • 全球腫瘤栓塞設備市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 放射栓塞術
  • 非放射性栓塞劑
  • 全球腫瘤栓塞設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 癌症腫瘤
  • 非癌性腫瘤
  • 全球腫瘤栓塞設備市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 癌症治療中心
  • 加護病房
  • 手術中心
  • 全球腫瘤栓塞設備市場：依放射栓塞劑（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 釔-90（Y-90）微球
  • 钬166微球
  • 全球腫瘤栓塞設備市場：依非放射性栓塞劑（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型珠（DEB）
  • 微球（聚乙烯醇-PVA顆粒）
  • 明膠海綿
  • 液體栓塞劑（Onyx，黏合劑基）

第7章 區域和國家分析

  • 全球腫瘤栓塞設備市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腫瘤栓塞設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 腫瘤栓塞裝置市場：競爭格局
  • 腫瘤栓塞裝置市場：公司簡介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Cook Medical LLC
  • AngioDynamics Inc.
  • Siemens Healthineers AG
  • Johnson & Johnson
  • Penumbra Inc.
  • Teleflex Incorporated
  • Meril Life Sciences Pvt. Ltd.
  • Kaneka Corporation
  • Imagion Biosystems Ltd.
  • Guerbet
  • BTI Biotechnology Institute SL
  • BTG International
  • Avinger Inc.
  • Shape Memory Medical Inc.
  • Delcath Systems Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年腫瘤栓塞設備市場：提供新機會的國家
  • 2029年腫瘤栓塞設備市場：細分市場帶來新機會
  • 2029年腫瘤栓塞設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32828u

Tumor embolization devices are minimally invasive instruments employed in the treatment of tumors. These devices serve the purpose of either occluding the blood supply to the tumor or delivering therapeutic agents directly to the tumor site.

The primary categories of tumor embolization devices include radioembolic agents and non-radioactive embolic agents. Non-radioactive embolic agents encompass materials like gelatin foam, tris-acryl gelatin microspheres, and polyvinyl alcohol (PVA) that are utilized in the treatment of tumors. These applications are relevant to both cancerous and noncancerous tumors, and the devices are employed by various end-users, including hospitals, cancer treatment centers, intensive care units, and surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tumor embolization devices market research report is one of a series of new reports from The Business Research Company that provides tumor embolization devices market statistics, including tumor embolization devices industry global market size, regional shares, competitors with a tumor embolization devices market share, detailed tumor embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor embolization devices industry. This tumor embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor embolization devices market size has grown strongly in recent years. It will grow from $1493.6 billion in 2024 to $1587.48 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population.

The tumor embolization devices market size is expected to see strong growth in the next few years. It will grow to $2254.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, image-guided embolization, telemedicine and remote consultations. Major trends in the forecast period include innovations in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, image-guided procedures.

The forecast of 9.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for calibrated microspheres and detachable embolization coils, sourced from key regions such as Ireland and Spain, could lead to higher costs for interventional oncology procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing global prevalence of cancer is expected to drive the growth of the tumor embolization devices market during the forecast period. For example, in October 2022, Macmillan Cancer Support, the largest healthcare charity in the UK, projected that the number of cancer cases would reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising cancer incidence worldwide is likely to fuel the demand for tumor embolization devices in the coming years.

The growth in healthcare expenditures is set to drive the tumor embolization devices market. Healthcare expenditures include all costs related to providing healthcare services, such as family planning, nutrition programs, and emergency health assistance. Increased spending in healthcare facilitates the development of various health-related products, including tumor embolization devices. For instance, according to economic forecasts from the Office for Budget Responsibility (OBR) and the Treasury, a UK-based non-departmental public body, the UK's health spending is expected to rise to £192 billion ($244.43 billion) in 2024/25, compared to £182 billion ($231.70 billion) in 2022/23. Thus, the increase in healthcare expenditures is a key factor driving the growth of the tumor embolization devices market.

Key players in the tumor embolization devices market are developing innovative products, such as angiography systems, to improve the accuracy and effectiveness of tumor-targeted treatments. Angiography systems are specialized imaging tools used to visualize blood vessels and evaluate blood flow within the body. For example, in June 2022, Siemens Healthineers, a Germany-based healthcare company, introduced the Artis Icono Ceiling. This ceiling-mounted angiography system is designed to enhance precision in tumor embolization and other interventional procedures. The Artis Icono Ceiling features rapid three-dimensional (3D) data acquisition, capturing images at the patient's head in just 2.5 seconds and from the sides in 4 seconds. This minimizes motion artifacts and reduces the need for contrast media. The system is versatile, making it suitable for various specialties, including interventional radiology and cardiology.

Major companies in the tumor embolization devices market are emphasizing the introduction of innovative treatments, such as Eye90, to maximize market revenue. Eye90 microspheres are a Y90 radioembolization device specifically designed for the treatment of liver tumors, particularly hepatocellular carcinoma. In May 2023, ABK Biomedical, a Canada-based medical device company, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a multicenter pivotal study of Eye90 microspheres in hepatocellular carcinoma. These microspheres are produced through a proprietary manufacturing process, resulting in uniform size distribution and high radioactivity concentration. They are designed to deliver a high dose of radiation to the tumor while minimizing exposure to healthy tissue.

In August 2022, Boston Scientific, a US-based medical device manufacturer, acquired Obsidio Inc. to strengthen its portfolio in interventional oncology and embolization. Obsidio is a US-based developer of embolization gel.

Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

North America was the largest region in the tumor embolization devices market in 2024. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor embolization devices market consists of sales of radioembolic agents and non-radioactive embolic agents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Embolization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Radioembolic Agents; Non-radioactive Embolic Agents
  • 2) By Application: Cancer Tumors; Noncancerous Tumors
  • 3) By End User: Hospitals; Cancer Treatment Centers; Intensive Care Units; Surgical Centers
  • Subsegments:
  • 1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres; Holmium-166 Microspheres
  • 2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs); Microspheres (Polyvinyl Alcohol - PVA Particles); Gelatin Sponges; Liquid Embolic Agents (Onyx, Glue-Based Agents)
  • Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Terumo Corporation; Sirtex Medical Limited; Merit Medical Systems Inc.; Cook Medical LLC; AngioDynamics Inc.; Siemens Healthineers AG; Johnson & Johnson; Penumbra Inc.; Teleflex Incorporated; Meril Life Sciences Pvt. Ltd.; Kaneka Corporation; Imagion Biosystems Ltd.; Guerbet; BTI Biotechnology Institute S.L.; BTG International; Avinger Inc.; Shape Memory Medical Inc.; Delcath Systems Inc.; Endoshape Inc.; InSitu Technologies Inc.; Monteris Medical Corporation; NeuWave Medical Inc.; Neoprobe Corporation; OncoSec Medical Incorporated; Helomics Corporation; Hologic; Surefire Medical Inc.; Varian Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Embolization Devices Market Characteristics

3. Tumor Embolization Devices Market Trends And Strategies

4. Tumor Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Embolization Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Embolization Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Embolization Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Embolization Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Embolization Devices Total Addressable Market (TAM)

6. Tumor Embolization Devices Market Segmentation

  • 6.1. Global Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radioembolic Agents
  • Non-radioactive Embolic Agents
  • 6.2. Global Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Tumors
  • Noncancerous Tumors
  • 6.3. Global Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cancer Treatment Centers
  • Intensive Care Units
  • Surgical Centers
  • 6.4. Global Tumor Embolization Devices Market, Sub-Segmentation Of Radioembolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Yttrium-90 (Y-90) Microspheres
  • Holmium-166 Microspheres
  • 6.5. Global Tumor Embolization Devices Market, Sub-Segmentation Of Non-radioactive Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Beads (DEBs)
  • Microspheres (Polyvinyl Alcohol - PVA Particles)
  • Gelatin Sponges
  • Liquid Embolic Agents (Onyx, Glue-Based Agents)

7. Tumor Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Embolization Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Embolization Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Embolization Devices Market

  • 8.1. Asia-Pacific Tumor Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Embolization Devices Market

  • 9.1. China Tumor Embolization Devices Market Overview
  • 9.2. China Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Embolization Devices Market

  • 10.1. India Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Embolization Devices Market

  • 11.1. Japan Tumor Embolization Devices Market Overview
  • 11.2. Japan Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Embolization Devices Market

  • 12.1. Australia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Embolization Devices Market

  • 13.1. Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Embolization Devices Market

  • 14.1. South Korea Tumor Embolization Devices Market Overview
  • 14.2. South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Embolization Devices Market

  • 15.1. Western Europe Tumor Embolization Devices Market Overview
  • 15.2. Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Embolization Devices Market

  • 16.1. UK Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Embolization Devices Market

  • 17.1. Germany Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Embolization Devices Market

  • 18.1. France Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Embolization Devices Market

  • 19.1. Italy Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Embolization Devices Market

  • 20.1. Spain Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Embolization Devices Market

  • 21.1. Eastern Europe Tumor Embolization Devices Market Overview
  • 21.2. Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Embolization Devices Market

  • 22.1. Russia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Embolization Devices Market

  • 23.1. North America Tumor Embolization Devices Market Overview
  • 23.2. North America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Embolization Devices Market

  • 24.1. USA Tumor Embolization Devices Market Overview
  • 24.2. USA Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Embolization Devices Market

  • 25.1. Canada Tumor Embolization Devices Market Overview
  • 25.2. Canada Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Embolization Devices Market

  • 26.1. South America Tumor Embolization Devices Market Overview
  • 26.2. South America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Embolization Devices Market

  • 27.1. Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Embolization Devices Market

  • 28.1. Middle East Tumor Embolization Devices Market Overview
  • 28.2. Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Embolization Devices Market

  • 29.1. Africa Tumor Embolization Devices Market Overview
  • 29.2. Africa Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Embolization Devices Market Competitive Landscape
  • 30.2. Tumor Embolization Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Cook Medical LLC
  • 31.2. AngioDynamics Inc.
  • 31.3. Siemens Healthineers AG
  • 31.4. Johnson & Johnson
  • 31.5. Penumbra Inc.
  • 31.6. Teleflex Incorporated
  • 31.7. Meril Life Sciences Pvt. Ltd.
  • 31.8. Kaneka Corporation
  • 31.9. Imagion Biosystems Ltd.
  • 31.10. Guerbet
  • 31.11. BTI Biotechnology Institute S.L.
  • 31.12. BTG International
  • 31.13. Avinger Inc.
  • 31.14. Shape Memory Medical Inc.
  • 31.15. Delcath Systems Inc.

32. Global Tumor Embolization Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Embolization Devices Market

34. Recent Developments In The Tumor Embolization Devices Market

35. Tumor Embolization Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Embolization Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Embolization Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Embolization Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer